BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12916872)

  • 1. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein.
    Sykes DB; Scheele J; Pasillas M; Kamps MP
    Leuk Lymphoma; 2003 Jul; 44(7):1187-99. PubMed ID: 12916872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
    Chang CP; de Vivo I; Cleary ML
    Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.
    Woodcroft MW; Nanan K; Thompson P; Tyryshkin K; Smith SP; Slany RK; LeBrun DP
    PLoS One; 2015; 10(6):e0130495. PubMed ID: 26098938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
    Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
    Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins.
    Sykes DB; Kamps MP
    Blood; 2001 Oct; 98(8):2308-18. PubMed ID: 11588024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
    Lu Q; Kamps MP
    Oncogene; 1997 Jan; 14(1):75-83. PubMed ID: 9010234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
    Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
    Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
    Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
    Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
    Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1.
    Smith KS; Chanda SK; Lingbeek M; Ross DT; Botstein D; van Lohuizen M; Cleary ML
    Mol Cell; 2003 Aug; 12(2):393-400. PubMed ID: 14536079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.
    Fu X; Kamps MP
    Mol Cell Biol; 1997 Mar; 17(3):1503-12. PubMed ID: 9032278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.
    McWhirter JR; Goulding M; Weiner JA; Chun J; Murre C
    Development; 1997 Sep; 124(17):3221-32. PubMed ID: 9310317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
    Sykes DB; Kamps MP
    Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
    Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
    Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
    Smith KS; Jacobs Y; Chang CP; Cleary ML
    Oncogene; 1997 Jun; 14(24):2917-26. PubMed ID: 9205098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
    Kamps MP; Wright DD
    Oncogene; 1994 Nov; 9(11):3159-66. PubMed ID: 7936638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.